Evidence map›Paper›PMID 41171526›Full record

ArticleActa neurologica Belgica2026

Atypical clinical manifestation of MT-TL1 mutation in 6 months old patient.

Joanna Janiak, Weronika Piątkowska, Patrycja Podlejska, Dawid Zakrzewski, Marta Zawadzka, Agnieszka Sawicka, Maria Mazurkiewicz-Bełdzińska

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Acta neurologica Belgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joanna JaniakDepartment of Developmental Neurology, Medical University of Gdańsk, Ul. Dębinki 7, 80-952, Gdańsk, Poland.ORCID http://orcid.org/0009-0000-7617-1082
Weronika PiątkowskaDepartment of Developmental Neurology, Medical University of Gdańsk, Ul. Dębinki 7, 80-952, Gdańsk, Poland.ORCID http://orcid.org/0009-0004-7211-942X
Patrycja PodlejskaDepartment of Developmental Neurology, Medical University of Gdańsk, Ul. Dębinki 7, 80-952, Gdańsk, Poland.ORCID http://orcid.org/0009-0002-0074-9778
Dawid ZakrzewskiDepartment of Developmental Neurology, Medical University of Gdańsk, Ul. Dębinki 7, 80-952, Gdańsk, Poland.ORCID http://orcid.org/0000-0002-8265-5232
Marta ZawadzkaDepartment of Developmental Neurology, Medical University of Gdańsk, Ul. Dębinki 7, 80-952, Gdańsk, Poland. marta.zawadzka@gumed.edu.pl.ORCID http://orcid.org/0000-0003-4562-1882
Agnieszka SawickaDepartment of Developmental Neurology, Medical University of Gdańsk, Ul. Dębinki 7, 80-952, Gdańsk, Poland.
Maria Mazurkiewicz-BełdzińskaDepartment of Developmental Neurology, Medical University of Gdańsk, Ul. Dębinki 7, 80-952, Gdańsk, Poland.ORCID http://orcid.org/0000-0002-9405-5066

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mitochondrial tRNALeu (MT-TL1) m.3243A > G mutation is one of the most frequent pathogenic variants in mtDNA which is associated with various clinical syndromes including Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS). The onset of symptoms associated with the MT-TL1 mutation typically occurs in adolescence or early adulthood. Due to the diversity of its clinical presentation, there is a need to report all cases that do not fully meet the criteria of well-established clinical syndromes. CASE PRESENTATION: This paper reports a case of a 3-year-old male patient with a complex perinatal history, whose symptoms emerged at 6 months of age and included epileptic seizures, developmental delay, bilateral convergent strabismus, hypertonia, hyperreflexia, and radiological brain abnormalities. The family history is positive for epilepsy and hearing impairment in females on the maternal side. Genetic testing revealed a pathological variant in the MT-TL1 gene m.3243A > G with a high heteroplasmy level of 76.5% in the blood sample.

conclusionThe case presents an atypical manifestation of the m.3243A > G mutation, highlighting the importance of genetic screening for mitochondrial disorders in patients with a maternal family history.

Indexed as

MELAS SyndromeMitochondrial DiseasesMutationRNA, Transfer, LeuChild, PreschoolHumansMaleMT-TL1 tRNA, humanRNA, Transfer, LeuAtypical MT-TL1Lactic acidosisMELASMitochondrial encephalopathyMitochondrial mutationMT-TL1 mutationStroke

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.